The original headline is: "This New Medicare Pilot Program Offers GLP-1s For $50 A Month. Here's What You Need To Know"

Short summary

Medicare has launched Bridge, a temporary pilot program offering GLP-1 medications at a capped monthly cost of $50 for beneficiaries with BMI exceeding 35 or obesity-related comorbidities, according to CNBC's reporting. The program addresses rising medication costs and aims to improve access to weight-management treatment. As a healthcare policy story rather than AI/tech industry news, its utility for an AI-focused professional feed is minimal.

• •Medicare Bridge pilot caps GLP-1 costs at $50/month for eligible beneficiaries
• •Requires BMI >35 or obesity-related conditions
• •Off-topic for AI-news feed; flags as medical/regulated-industry

Generated with AI, which can make mistakes.